Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) Injection, Powder, Lyophilized, For Suspension
Product Images NDC 71288-183

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) (NDC 71288-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg Carton)

Carton label for Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) 100 mg per vial, a lyophilized powder for suspension injection by intravenous use. The label includes handling and storage instructions, warns against substitution, and is manufactured by Meitheal Pharmaceuticals Inc. The label displays the NDC 71288-183 and a barcode.*

FDA Label Image

Figure 1 (Paclitaxel Figure 1)

A survival curve chart comparing the proportion of survival over time in months between Paclitaxel protein-bound particles for injectable suspension (albumin-bound) combined with Gemcitabine (solid line) and Gemcitabine alone (dashed line). The chart includes the number of patients at risk at various time points for each treatment group.*

FDA Label Image

Preparation Vial (Paclitaxel Prep Vial)

An instructional illustration showing the preparation of a vial of Paclitaxel protein-bound particles for injectable suspension, with an intravenous solution being inserted into the vial via a syringe or needle, indicating reconstitution or dilution for intravenous administration.*

FDA Label Image

Structural Formula For Paclitaxel (Paclitaxel Structure)

Chemical structure of paclitaxel, the active ingredient in Paclitaxel protein-bound particles for injectable suspension (albumin-bound). The diagram shows molecular bonds and functional groups characteristic of paclitaxel.*

FDA Label Image

Principal Display Panel (100 mg Vial)

Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) 100 mg per vial, a single-dose lyophilized powder injection for intravenous use. The label includes instructions for reconstitution with 20 mL of 0.9% sodium chloride and usage notes. The product is labeled by Meitheal Pharmaceuticals Inc., with storage conditions specified and a barcode present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.